FDA Inspection 1232428 — Haleon US Holdings LLC
The FDA completed an inspection of Haleon US Holdings LLC on November 22, 2024 in Warren, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 22, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Warren, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)